Inaccuracy of calculated LDL-cholesterol in type 2 diabetes: Consequences for patient risk classification and therapeutic decisions

Clinical Chemistry

Volumn 46, Issue 11, 2000, Pages 1830-1832

  Wagner, A M ^a   Sanchez Quesada, J L ^a   Perez, A ^a   Rigla, M ^a   Cortes, M ^a   Blanco Vaca, F ^a   Ordonez Llanos, J ^a  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ACCURACY; ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; FEMALE; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; RISK ASSESSMENT; TREATMENT PLANNING;

EID: 0033756353     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/46.11.1830     Document Type: Article

References (28)

1. Management of dyslipidemia in adults with diabetes
2. Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel II)
3. Measurement of low-density lipoprotein cholesterol
4. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge
5. National Cholesterol Education Program recommendations for measurement of low-density lipoprotein cholesterol: Executive summary
6. Influence of intermediate-density lipoproteins on the accuracy of the Friedewald formula
7. Limitations of the Friedewald formula for estimating low-density lipoprotein cholesterol in alcoholics with liver disease
8. VLDL subfractions composition in Pima Indians with type 2 diabetes mellitus: Comparison with non-diabetic control subjects
9. Increased cholesterol concentration in intermediate density lipoprotein fraction of normolipidemic non-insulin-dependent diabetics
10. Lipids and lipoproteins as coronary risk factors in non-insulin-dependent diabetes mellitus
11. Calculated low-density lipoprotein cholesterol should not be used in the management of lipoprotein abnormalities in patients with diabetes mellitus
12. A more valid measurement of low-density lipoprotein cholesterol in diabetic patients
13. Accuracy of calculated serum low-density lipoprotein cholesterol for the assessment of coronary heart disease risk in NIDDM patients
14. National Cholesterol Education Program recommendations for measurement of high-density lipoprotein cholesterol: Executive summary
15. Reference standardization and triglyceride interference of a new homogeneous HDL-cholesterol assay compared with a former chemical precipitation assay
16. Calculation of LDL cholesterol using apolipoprotein B for the phenotypical classification of non-chylomicronemic dyslipemia
17. Apolipoprotein B identifies dyslipidemic phenotypes associated with cardiovascular risk in normocholesterolemic type 2 diabetic patients
18. Enzymatic determination of total serum cholesterol
19. Triglyceride measurements: A review of methods and interferences
20. Direct measurement of high-density lipoprotein cholesterol in serum with polyethylene glycol-modified enzymes and sulfated α-cyclodextrin
21. International Federation of Clinical Chemistry standardization project for measurements of apolipoproteins A-I and B. IV. Comparability of apolipoprorein B values by use of International Reference Material
22. Some common problems in medical research
23. The prospective cardiovascular Munster (PROCAM) study: Prevalence of hyperlipidemia in persons with hypertension and/or diabetes mellitus and the relationship to coronary heart disease
24. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction
25. New immunoseparation-based homogeneous assay for HDL-cholesterol compared with three homogeneous and two heterogeneous methods for HDL-cholesterol
26. Measurement and clinical significance of apolipoproteins A-I and B
27. Apolipoprotein B and coronary artery disease in women
28. Prevalence of dyslipidemic phenotypes in ischemic heart disease (prospective results from the Quebec Cardiovascular Study)